Assessment of viable myocardium by nitrate augmented 99mTc MIBI myocardial perfusion imaging

Journal of the Pakistan Medical Association

Volumn 57, Issue 2, 2007, Pages 83-87

  Niyaz, Kashif ^a   Niaz, Khalid ^a   Uz Zaman, Maseeh ^a   Kamal, Shahid ^a   Usmani, Sharjeel ^a   Habib, Salman ^a   Hashmi, Hina ^a   Husssain, S Waqar ^a  

^a Karachi Institute of Radiotherapy & Nuclear Medicine   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE; DIAGNOSTIC AGENT; GLYCERYL TRINITRATE; RADIOPHARMACEUTICAL AGENT; THALLIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE PERFUSION; HEART PERFUSION; HEMODYNAMICS; HUMAN; IMAGING SYSTEM; MALE; AGED; HEART MUSCLE ISCHEMIA; MIDDLE AGED; PATHOPHYSIOLOGY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NITROGLYCERIN; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34047250446     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. 99m sestamibi with Rest-Redistribution Thallium-201 Tomography in Detecting viable myocardium and detecting Postrevascularization Recovery. J Am Coll Cardiol 1997; 30:384-91.
2. Vernon S, Kaul S, Eric R, Camarano G, Lawrence W et al. Myocardial Viability in Patients with Chronic Coronary Artery Disease and Previous Myocardial Infarction: Comparison of Myocardial Contrast Echocardiography and Myocardial Perfusion Scintigraphy. Am Heart J 1997; 134: 835-840
3. Schinel AF, Bax J, Sozzi F. Prevalence of Myocardial Viability. Heart 2002; 88:125-30.
4. Cardiovascular system. In: Thralls JH, Ziessmann HA. Nuclear Medicine; The Requisites, 2nd edition. Missouri: Mosby; 2001, pp 65-109.
5. 99m MIBI for assessing viable myocardium. J Nucl Med 1992; 33: 815-18.
6. Ortega-Alcalde D. Myocardial perfusion studies. In: Candell-Riera J, Ortega-Alcalde D eds. Nuclear Cardiology in Every Day Practice. Dordrecht: Kluwer Academic, 1994, pp 67-87.
7. 99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol 1996; 27: 1592-7.
8. Acampa W, He W, di Nuzzo C, Cuocolo A. Quantification of SPECT myocardial perfusion imaging. J Nucl Cardiol 2002; 9: 338-42.
9. 99m sestamibi uptake in coronary artery disease. Eur J Nucl Med 1993; 20: 502-10.
10. Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med 1992; 33 : 1925-30.
11. Katzung BG, Chatterjee K. Vasodilators and treatment of angina pectoris. In Katzung BG, eds. Basic and clinical pharmacology, 6th edition. USA: Appleton and Lange 1995, pp 172-78.
12. 99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995; 36: 1945-52.
13. 99m Sestamibi tomoscintigraphy on resting global myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol 1994; 74:843-48.
14. 99m Sestamibi in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories J Am coll cardiol 1994; 24: 1282-9
15. 99m sestamibi imaging to predict left ventricular ejection fraction outcome after revascularization in patients with chronic coronary artery disease and left ventricular dysfunction: comparison between baseline and nitrate-enhanced imaging. Eur J Nucl Med 2001; 28: 680-7.
16. 99m-sestamibi imaging with nitrate infusion to detect hibernating myocardium and predict post revascularization recovery. J Nuci Med 1995; 36: 1994-2000.